Even though the authors did not further investigate the molecular pathway underlying the inhibition of migration, previous studies in the literature provide a possible explanation: paclitaxel promoted the activation of NF-κB in breast cancer cells while curcumin inhibited its expression by inhibiting IκBα kinase activation. The gene discussed is NFKB1; the disease is breast carcinoma.